tirzepatide clinical trials for Obesity Treatment and Diabetes Prevention Highlighting 3 ongoing clinical trials

Patients pay a flat monthly rate that includes the medical consult, the medication, and all required supplies

In contrast, 31% of people using a placebo lost about 6 pounds, or about 2.5% of their body weight

Strive Compounding Pharmacy received formal disciplinary action from the Arizona State Board of Pharmacy in February 2024 for improper semaglutide compounding and inaccurate compounding records, resulting in a $1,000 civil penalty

Whether you're uninsured, self-insured, have a high-deductible plan, or face denials from your insurer, PlexusDx provides immediate access to telehealth consultation and compounded GLP-1 therapy at predictable, affordable monthly rates

That is why the FDA approved injectable peptide drugs list includes insulin products, GLP-1 receptor agonists such as semaglutide and tirzepatide, PTH analogs such as teriparatide and palopegteriparatide, tesamorelin, glucagon rescue products, and several diagnostic or oncology-related peptide agents